-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Written by Nie Yuru
Responsible editor—Wang Sizhen, Fang Yiyi
Editor—Summer Leaf
Neuropsychiatric diseases are a significant cause of disability and death worldwide, taking a huge toll
on individuals, families and health systems.
Sleep disturbance is a common clinical symptom
in patients with neuropsychiatric disorders.
In the past, sleep disturbances were seen as clinical symptoms
caused by pathological changes in neuropsychiatric disorders.
There is growing evidence of complex interactions and potential bidirectional causal relationships
between sleep disorders and these disorders.
Sleep disorders can predict the development of neuropsychiatric disorders (eg, depression, anxiety, and neurodegeneration) longitudinally, and effective treatment of neuropsychiatric disorders can improve sleep disorder symptoms [1-3].
Therefore, clarifying the relationship between sleep and neuropsychiatric disorders may help to understand the pathological mechanisms of these disorders [4].
Polysomnography (PSG) is the gold standard
for objectively assessing an individual's sleep characteristics.
Exploring the PSG sleep characteristic variables in patients with neuropsychiatric disorders has the potential to reveal the neurobiological mechanisms of specific diseases, as well as the commonalities and differences between different diseases [5].
Recent studies have found that meta-analyses are susceptible to reporting bias, publication bias, residual confounding bias, and other types of issues that may lead to overestimation of the parameters of the data being tested [6].
Such defects can lead to false-positive results [7], which may mask the most important or significant neurobiological features
of a particular disease.
Therefore, we used an umbrella analysis method to assess the strength of the evidence, the precision of the estimates, robustness, and possible bias for changes in nocturnal PSG characteristics for different neuropsychiatric disorders
.
On November 15, 2022, Professor Tang Xiangdong's team from the Sleep Medicine Center of West China Hospital of Sichuan University published a title in Psychological Medicine "Patterns of polysomnography parameters in 27 neuropsychiatric diseases: an umbrella review
.
" In the article, the researchers explored and compared schizophrenia, bipolar disorder, generalized anxiety disorder, depression, obsessive-compulsive disorder, post-traumatic stress disorder, autism spectrum disorder, anorexia nervosa, stroke, epilepsy, Alzheimer's disease, Parkinson's disease, Huntington's disease, migraine, and traumatic brain injury through umbrella analysis27 The macroscopic and microscopic sleep structure patterns of neuropsychiatric diseases differed, and the results showed that different neuropsychiatric diseases had completely different overall changes in
PSG.
The overall pattern of PSG change is an important dimension that reflects the neuropathological characteristics of different neuropsychiatric disorders.
(Further reading: For the relevant research progress of Tang Xiangdong's research group, see the "Logical Neuroscience" report (click to read):.
) Neurosci Biobehav Rev—Tang Xiangdong's team explores the pharmacological and psychotherapeutic efficacy of PTSD nightmares).
The results of the analysis showed that the overall pattern of sleep changes varied widely between different diseases (Figure 1).
Compared to healthy controls, patients with major depressive disorder (MDD) had sleep latency SL), decreased sleep efficiency (SE), increased percentage sleep in NREM stage 1 in patients with narcolepsy, Parkinson's disease Decrease in REM sleep percentage during the REM phase of disease (PD) is evidence
with a highly suggestive level 。 These findings can also be observed in other neuropsychiatric disorders such as post-traumatic stress disorder, schizophrenia, and Huntington's disease, although the level of confidence in the evidence varies
.
This suggests that changes in individual PSG parameters should be considered as cross-diagnostic sleep features for various neuropsychiatric disorders, rather than signature sleep features
for specific diseases.
There is still a lack of strong evidence that any single change in sleep parameters is specific to
a particular disease.
Observing the overall pattern of changes in PSG found that neither disease had the same overall pattern of changes in sleep characteristics (Figure 1), indicating PSG The overall pattern of change characteristic may be a specific marker
to distinguish between different disease diagnoses.
Fig.
1 Change pattern of sleep parameters (standardized mean difference)
in 27 patients with neuropsychiatric diseases.
(Source: Zhang Y et al.
, Psychol Med, 2022).
Fig.
2 Confidence in polysomnography changes for 27 neuropsychiatric disorders
.
(Source: Zhang Y et al.
, Psychol Med, 2022).
Of the 321 pooled analyses, none had a convincing (convincing) PSG differential strength according to the quantitative umbrella analysis criteria (Figure 2)
。 Only seven (2.
2%) analyses were supported by highly suggestive evidence: people with MDD SL increased, SE decreased; Patients with narcolepsy have increased NREM stage 1 sleep percentage, NREM 2 stage sleep percentage, SL and REML (rapid eye movement sleep latency).
) lower; The percentage of REM sleep is reduced
in PD patients.
.
Although the level of evidence for PSG features in 27 neuropsychiatric disorders varied across different PSG variables and across disorders, available evidence suggests PSG for different neuropsychiatric disorders The overall change pattern is different, suggesting that the overall change pattern of PSG can be used as an important dimension
to distinguish different neuropsychiatric diseases.
This provides further evidence
for further understanding of the neuropathological features of different neuropsychiatric disorders.
The study still has some limitations
.
It can be summarized as follows: 1 In this umbrella analysis, for diseases with low incidence such as Huntington's disease, Wilson's disease, and social anxiety disorder, the number of included literature is small and the sample size of patients is small, so the PSG characteristics of these diseases still need to be further verified
.
2.
The influence of gender, age and other demographic factors on the change of the overall pattern of PSG in different neuropsychiatric diseases is an important research direction
in the future.
3.
This umbrella analysis did not include changes in the overall pattern of PSG for all neuropsychiatric disorders such as multiple sclerosis, restless legs syndrome, and the strength of the evidence remains unclear
.
Original link: #
The research was supported by the Science and Technology Innovation 2030 "Brain Science and Brain-like Research" major project (2021ZD0201900) and the National Natural Science Foundation of China International (regional) Cooperation and Exchange Key Project (82120108002).
)
。
First author: Zhang Ye (left); Corresponding author: Tang Xiangdong (right).
(Photo courtesy of Tang Xiangdong Research Group)
Welcome to scan the code to join Logical Neuroscience Literature Study 2
Group Note Format: Name--Field of Research-Degree/Title/Title/PositionSelected Previous Articles[1] The PNAS-Liu Junyu team revealed the important role of connexin hemichannels in alleviating neuroinflammation and overexcitability during the pathogenesis of temporal lobe epilepsy
[2] iScience—Rogers/Yu Lezheng teamwork to develop tools for deep learning model understanding and visualization
[3] Transl Psychiatry—Suiqiang Zhu/Zhou Zhu's team revealed that structural disconnection caused by stroke predicts the risk of depression after stroke
[4] Neurosci Bull-Dandan Zhang's team reports the benefits of implicit cognitive reassessment on mood regulation in depression: evidence from behavioral and electrophysiology
[5] Cell Reports—Li's team revealed the basis of the neural circuits that occur in the irritable mental symptoms of Alzheimer's disease
[6] NAR—PGG.
MHC: gene database and analysis platform for major human histocompatibility complexes
[7] The Neuron-Niu Jianqin/Yi Chen Ju team discovered the coupling mechanism between the differentiation of oligodendrocytes and the formation of astrocytes foot processes in the developing oligodendrocyte
【8】Cell Reports | Zhang Jiyan's team revealed the presence and characteristics of hematopoietic stem cells in the meninges of adult mice
[9] The Neurosci Bull-Wang Shouyan/Qiu Zilong team reported abnormal prefrontal nerve oscillations associated with social disorders in MECP2 doubling syndrome
[10] Transl PsychiatryLaibin/Zheng Ping's research group revealed that CREB and GR mediate chronic morphine-induced decrease in miR-105 in the medial prefrontal cortex
Recommended high-quality scientific research training courses【1】Symposium on patch clamp and optogenetics and calcium imaging technology (January 7-8, 2023, Tencent Meeting)【2】The 10th NIR Training Camp (Online: 2022.11.
30~12.
20)【3】The 9th EEG Data Analysis Flight (Training Camp: 2022.
11.
23—12.
24) Welcome to "Logical Neuroscience"[1]" Logical Neuroscience "Recruitment Associate Editor/Editor/Operation Position (Online Office)[2] Talent Recruitment - " Logical Neuroscience " Recruitment Article Interpretation/Writing Position ( Online Part-time, Online Office )
Reference Reference (Swipe up and down to read).
[1] Galbiati, A.
, Verga, L.
, Giora, E.
, et al.
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies.
Sleep Medicine Reviews, 2019, 43, 37–46.
[2] Hertenstein, E.
, Feige, B.
, Gmeiner, T.
, et al.
Insomnia as a predictor of mental disorders: A systematic review and meta-analysis.
Sleep Medicine Reviews, 2019, 43, 96–105.
[3] Shi, L.
, Chen, S.
J.
, Ma, M.
Y.
, et al.
Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis.
Sleep Medicine Reviews, 2017, 40, 4–16.
[4] Krystal, A.
D.
Sleep therapeutics and neuropsychiatric illness.
Neuropsychopharmacology, 2020, 45(1), 166–175.
[5] Baglioni, C.
, Nanovska, S.
, Regen, W.
, et al.
Sleep and mental disorders: A meta-analysis of polysomnographic research.
Psychological Bulletin, 2016, 142(9), 969–990.
[6] Ioannidis, J.
P.
Why most published research findings are false.
PLoS Medicine, 2005, 2(8), e124.
[7] Ioannidis, J.
P.
, Munafo, M.
R.
, Fusar-Poli, P.
, et al.
Publication and other reporting biases in cognitive sciences: Detection, prevalence, and prevention.
Trends in Cognitive Sciences, 2014, 18(5), 235–241.
End of article